Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bio-Rad Laboratories (BIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 6,493,056
  • Shares Outstanding, K 29,600
  • Annual Sales, $ 2,068 M
  • Annual Income, $ 28,130 K
  • 36-Month Beta 0.92
  • Price/Sales 3.14
  • Price/Cash Flow 56.60
  • Price/Book 2.40

Price Performance

See More
Period Period Low Period High Performance
1-Month
212.47 +3.05%
on 04/26/17
224.24 -2.36%
on 05/05/17
+5.50 (+2.58%)
since 04/24/17
3-Month
191.61 +14.27%
on 02/27/17
224.24 -2.36%
on 05/05/17
+27.03 (+14.08%)
since 02/24/17
52-Week
135.94 +61.06%
on 06/27/16
224.24 -2.36%
on 05/05/17
+70.90 (+47.89%)
since 05/24/16

Most Recent Stories

More News
Bio-Rad Introduces Enhanced Options with its IH-Com Data Management Software for Managing Patient Results with the IH-1000 System

HERCULES, CA--(Marketwired - May 24, 2017) - Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIOb), a global provider of life science research and clinical diagnostic products, today announced that it has...

BIO : 218.95 (-0.19%)
52.0% Return Seen to Date on SmarTrend Bio-Rad Laboratories Call (BIO)

SmarTrend identified an Uptrend for Bio-Rad Laboratories (NYSE:BIO) on July 12th, 2016 at $144.77. In approximately 10 months, Bio-Rad Laboratories has returned 51.95% as of today's recent price of $219.99....

BIO : 218.95 (-0.19%)
TransEnterix (TRXC) Reports Wider-than-Expected Loss in Q1

TransEnterix, Inc. (TRXC) reported a loss of 13 cents per share in the first quarter of 2017, wider than the Zacks Consensus Estimate of a loss of 12 cents.

BAX : 58.34 (+0.73%)
BIO : 218.95 (-0.19%)
REGN : 458.24 (-0.68%)
TRXC : 0.51 (-3.77%)
Masimo (MASI) Beats on Q1 Earnings and Revenues, Guides Up

Masimo Corp. (MASI) reported earnings of 57 cents per share in the first quarter of 2017, outperforming the Zacks Consensus Estimate of 54 cents and improving from the year-ago quarterly earnings of 53...

MASI : 85.84 (+0.01%)
BAX : 58.34 (+0.73%)
BIO : 218.95 (-0.19%)
REGN : 458.24 (-0.68%)
Medtronic (MDT) Wins FDA Approval for CRT-P SureScan Suite

Medtronic plc (MDT) recently won FDA approval for a portfolio of quadripolar cardiac resynchronization therapy-pacemakers that improve therapy delivery for patients with heart failure.

BAX : 58.34 (+0.73%)
BIO : 218.95 (-0.19%)
MDT : 84.70 (+0.11%)
REGN : 458.24 (-0.68%)
STERIS (STE) Grapples with Headwinds: Should You Dump?

On May 10, we issued an updated research report on STERIS Plc (STE) which manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support...

STE : 76.67 (+0.51%)
BAX : 58.34 (+0.73%)
BIO : 218.95 (-0.19%)
REGN : 458.24 (-0.68%)
Hologic (HOLX) Tops Q2 Earnings & Sales, Raises 2017 View

Hologic Inc. (HOLX) reported second-quarter fiscal 2017 adjusted earnings per share (EPS) of 50 cents, up 6.4% year over year.

HOLX : 43.00 (+0.26%)
BAX : 58.34 (+0.73%)
BIO : 218.95 (-0.19%)
REGN : 458.24 (-0.68%)
Genomic Health (GHDX) Misses Q1 Earnings & Sales Estimates

Genomic Health, Inc. (GHDX) reported first-quarter 2017 loss per share of 7 cents, reflecting an improvement from the year-ago quarter's loss figure of 19 cents.

GHDX : 29.00 (-1.26%)
BAX : 58.34 (+0.73%)
BIO : 218.95 (-0.19%)
REGN : 458.24 (-0.68%)
Dull Q1 Earnings & Tough Industry Spell Trouble for BioScrip

On May 10, we issued an updated research report on BioScrip, Inc. (BIOS ), a pure-play Infusion Service provider.

BIOS : 1.73 (+0.58%)
BAX : 58.34 (+0.73%)
BIO : 218.95 (-0.19%)
REGN : 458.24 (-0.68%)
Becton (BDX) Announces $4.5B Follow-On Share Offerings

Becton, Dickinson and Company (BDX), popularly known as BD, recently announced a follow-on offering of $4.5 billion for its shares.

BCR : 308.44 (+0.03%)
BDX : 187.00 (+0.20%)
BAX : 58.34 (+0.73%)
BIO : 218.95 (-0.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials,...

See More

Support & Resistance

2nd Resistance Point 221.34
1st Resistance Point 220.14
Last Price 218.95
1st Support Level 217.99
2nd Support Level 217.04

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.